Rectal colonization with a fluoroquinolone-resistant organism identifies men who are at significantly increased risk for an infectious complication following prostate biopsy, according to the findings of a recent multi-institutional international collaborative study.
A study of contemporary trends in the management of upper tract calculi shows the approach to treatment is influenced by several provider-specific attributes and identifies a steady shift toward increasing use of ureteroscopy.
Stuart Holden, MD, has joined the UCLA faculty as a health sciences clinical professor in urology at the David Geffen School of Medicine. He was also appointed associate director of the UCLA Institute of Urologic Oncology, according to a UCLA press release.
Continent urinary diversion and postoperative complications were found to be independent predictors of hospital readmission following radical cystectomy in an analysis from the University of Wisconsin, Madison.
Drivers or passengers involved in motor vehicle collisions have reduced rates of high-grade renal injury and nephrectomy when wearing protective devices, according to research presented at an AUA press briefing on Friday.
Lumenis Ltd. has announced the U.S. launch of the Lumenis Pulse 120H Holmium laser platform for a range of urologic applications.
Anterior urethral strictures associated with hypospadias repair or lichen sclerosus pose a surgical challenge, often necessitating a staged approach to repair, using oral mucosa grafts. In a Cleveland Clinic study presented yesterday, multistage urethroplasty with buccal mucosa led to a high rate of durable patency, associated with a low incidence of complications and revisions.
Analyses of morbidity and mortality after surgery for BPH show that the current major modalities are all safe, but also identify patient attributes associated with an increased risk of complications.
The Protecting Access to Medicare Act of 2014 largely preserves the status quo for physicians and their Medicare patients, but many believe the health care model is ripe for disruptive innovation.
In this edition of "Coding Q&A," Ray Painter, MD, and Mark Painter also discuss the use of the –59 modifier when instilling mitomycin after TURBT, and whether you can charge for a establishing a treatment on the same day for a patient on whom you have just performed a cystoscopy.
Other cases discussed in this edition of "Malpractice Consult" include cecum perforated during prostatectomy, injections fail to improve Peyronie's disease, and dementia diagnosis blamed on urologic procedure.
Repealing the IOASE would severely curtail the health care options for hundreds of thousands of prostate cancer patients and their families who depend on access to comprehensive, integrated urologic services of the highest quality.
This article examines the relationship between the metabolic syndrome and kidney stone disease. We explain elements of the metabolic workup and practical strategies for prevention and management of stones in patients with the metabolic syndrome.
Studies examining the post-prostatectomy effects of phosphodiesterase type-5 inhibitors and those discussing active surveillance are among the key papers in localized prostate cancer to be presented at this year's AUA annual meeting, according to Leonard G. Gomella, MD.
Prostate cancer will not go away if we simply stop looking for it.
The FDA recently issued two proposed orders that, if finalized, would reclassify surgical mesh for transvaginal pelvic organ prolapse from a moderate-risk device (class II) to a high-risk device (class III) and require manufacturers to submit a premarket approval application for the agency to evaluate safety and effectiveness.
Despite their overall low risk, procedures to treat kidney stones lead to complications that require hospitalization or emergency care for one in seven patients, according to a recent study.
African-American and European-American men at high risk of prostate cancer have greater odds of being diagnosed with an aggressive form of the disease if they have vitamin D deficiency, researchers from Chicago’s Northwestern Medicine and the University of Illinois at Chicago reported in a recently published study.
New products and services from Lumenis, ITelagen, Mission Pharmacal, PatientPoint, and HealthTronics IT Solutions.
Of the myriad proposed solutions to physician shortages, an expanded scope of practice for non-physician providers can be swiftly implemented by policymakers eager for a quick fix. Unfortunately, quick fixes usually involve shoddy workmanship and, as applied to the provision of health care, shoddy workmanship endangers patient safety.
Urologists on Twitter criticized high-intensity focused ultrasound and in some instances even mocked the treatment.
Drugs and devices in the pipeline from MEI Pharma, Bayer HealthCare, Merck, Pfizer, and Minomic International.
Urologists discuss their approaches to preventing post-prostate biopsy infection, including rectal swabs and antibiotic prophylaxis.
When it comes to counseling patients on kidney stone prevention, less may be more, suggests a study presented at the National Kidney Foundation's spring clinical meetings in Las Vegas.
The Prostate Health Index (phi), a noninvasive blood test its developer says is three times more specific in detecting prostate cancer than PSA, is now available nationwide.
Analyses of serial magnetic resonance imaging and three-dimensional renderings of those images provide proof of principle for using convective thermal heating to ablate prostate tissue, and early evidence suggests the efficacy and potential clinical advantages of using this novel technology to treat BPH, said first author Lance A. Mynderse, MD, at the European Association of Urology annual congress in Stockholm, Sweden.
Sling surgery, robotic approaches to sacrocolpopexy and pelvic organ prolapse, and mesh are among the key studies in the area of female urology to watch for at the 2014 AUA annual meeting.
Intralesional injection of collagenase clostridium histolyticum (CCH [XIAFLEX]) improves the physical and psychological aspects of Peyronie’s disease in men regardless of erectile dysfunction severity and whether they have a history of prior treatment or prostatectomy, according to a recent study.
Focal therapy has been promoted as a minimally morbid option for men with localized low-risk prostate cancer who nevertheless want their disease treated. Opponents of focal therapy note the heterogeneity and multifocal nature of prostate cancer, the difficulty of accurately targeting and destroying an index tumor with focal therapy, and the unknown biologic potential of the tumor.
Researchers have come up with a potential blood-based biomarker that can identify men with castration-resistant prostate cancer who are not likely to respond to enzalutamide (XTANDI).